© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
NSCLC
Researchers Find “Medicare” Spike of Diagnoses of Lung, Other Common Cancers
April 02, 2021
Diagnoses spike in people's 65th year when most Americans become newly eligible for Medicare coverage.
Study Identified 25 Genetic Variants Linked with Lung Cancer Risk
April 01, 2021
Although smoking is the predominate risk factor for lung cancer, about 1 in 5 cases cases are believed to be linked to genetic factors.
Born In the USA Not an Advantage for Overall Survival From NSCLC
March 27, 2021
City of Hope researchers find longer overall survival rates among nonsmall cell lung cancer patients (NSCLC) who are immigrants. Could this be another instance of the healthy immigrant paradox?
New Lung Cancer Screening Recommendations Can Reach More Patients But Won't Remove All Barriers
March 11, 2021
The U.S. Preventative Services Task Force recently released an updated recommendation addressing lung cancer screening criteria at a sooner rate starting at 50-years-old rather than 55. The task force says this expansion will be especially helpful to those who face disparities to screening. Although, it won’t cover all disparities.
Crunching the Cost-Benefit Numbers of Immune Checkpoint Inhibitors for NSCLC
March 11, 2021
Population-level study of Medicare beneficiaries shows marked improvement in survival statistics but also an 8.6% jump in Medicare spending.
Tepotinib is Approved for Use to Treat Patients with METex14+ NSCLC
February 04, 2021
Based on results of the VISION study, the FDA has granted accelerated approval to tepotinib for MET exon 14 skipping altered metastatic non–small cell lung cancer.
COVID-19 Has Changed Cancer Care — For the Better
February 02, 2021
The pandemic has led to the adoption of telehealth and greater access to care through apps.
Cancer Organizations Join Forces to Endorse Screening During COVID-19
January 28, 2021
The organizations give recommendations on how to get patients to receive the care they need.
Similar Cancer Risk Between Patients With MS, General Population in the UK, Study Finds
October 23, 2020
Study found that while frequency of cancer among people with multiple sclerosis (MS) increased over time, the overall cancer risk is similar between patients with MS and the general population.
Otis Brawley: It’s Gotten Better but Problems With Cancer Screening Haven’t Gone Away
October 22, 2020
“Lung cancer screening is a great example of the problem,” says the former chief medical and scientific officer for the American Cancer Society in this third of four-part video series.
AstraZeneca's Adrian Kilcoyne Sees Paradigm Shift in Lung Cancer Treatment
June 02, 2020
Adrian Kilcoyne MD MBA MPH, vice president, US Medical Affairs and HEOR, oncology, AstraZeneca, discusses a paradigm shift in lung cancer treatment due to the overwhelming efficacy of the EGFR-TKI treatment.